This announcement is a separate document:
荣昌生物2024年第一次临时股东大会之法律意见书
Legal opinion on the first interim shareholder meeting of Remegen in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.